Heritability of Daytime Ambulatory Blood Pressure in an Extended Twin Design. by Kupper, H.M. et al.
Heritability of Daytime Ambulatory Blood Pressure in an
Extended Twin Design
Nina Kupper, Gonneke Willemsen, Harrie¨tte Riese, Danie¨lle Posthuma,
Dorret I. Boomsma, Eco J.C. de Geus
Abstract—The present study estimated the genetic influences on ambulatory systolic and diastolic blood pressure, and on
hypertensive status derived from ambulatory levels, in a family sample of 535 twins and 257 singleton siblings. This
“extended twin design” was used to explicitly test the possibility that results obtained in singleton siblings are different
from those obtained in twins. To examine the effects of excluding (medicated) hypertensive subjects, the genetic
analyses were first performed under strict exclusion (medication and/or blood pressure 135/85 mm Hg), then without
the medicated subjects, and, finally, without any exclusion. For the latter analysis, the untreated blood pressure values
in subjects using antihypertensive medication were estimated by augmenting the observed blood pressure by the
published efficacy of the specific antihypertensive medication used. No evidence was found for differential means,
variances, or covariances of ambulatory blood pressure in singletons compared with twins. This indicates that estimates
of heritability of ambulatory blood pressure from twin studies can be generalized to the singleton population. Heritability
of hypertension, defined as a mean daytime blood pressure 135/85 mm Hg or antihypertensive medication use, was
61%. Genetic contribution to ambulatory blood pressure was highest when all subjects were included (systolic, 44% to
57%; diastolic, 46% to 63%) and lowest under strict exclusion (systolic, 32% to 50%; diastolic, 31% to 55%). We
conclude that exclusion of (medicated) hypertensives removes part of the true genetic variance in ambulatory blood
pressure. (Hypertension. 2005;45:80-85.)
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Alarge number of twin and family studies have shownsignificant genetic contributions to individual differ-
ences in blood pressure (BP).1–5 Most of these studies have
based their genetic analyses on conventional office BP
measurements. The genetics of ambulatory BP (ABP) may
differ, however, because it is unaffected by the “white-coat”
effect.6 The added value of ABP measurements is best
illustrated by studies showing that ABP is a better predictor
of target organ damage,7 cardiovascular morbidity, and mor-
tality8,9 than conventional office BP.
To date, only 4 twin studies10–13 and 1 family study14
reported heritability estimates for daytime or 24-hour ABP.
Estimates ranged from 22% to 62% for systolic blood
pressure (SBP) and from 38% to 63% for diastolic blood
pressure (DBP). With the exception of studies by Vinck et
al12 and Fagard et al,13 sample sizes for the twin analyses
have been rather small, ie, at most, 66 pairs in total. Thus,
there is a relative paucity of adequately powered twin studies
on ambulatory measures. One way of increasing statistical
power is to include singleton siblings. Such an extended twin
design15 further provides an optimal design to address the
question whether results from twin studies on the genetics of
ABP may be generalized to the singleton population, because
it matches twins and singletons for familial factors like
socioeconomic status (SES), diet habits, and maternal behav-
iors during pregnancy.
Existing twin and family studies of ABP have excluded
subjects using antihypertensive medication,12,13 or have been
performed with analyses of normotensive subjects only,10,11
thereby removing an important part of the population vari-
ance of interest.16 The present study estimated the genetic
influences on hypertensive status and ambulatory SBP and
DBP in a large sample of twins and their singleton siblings.
To examine the effects of exclusion, the genetic analyses on
ABP were first performed on normotensive subjects only,
secondly after exclusion of medicated hypertensive subjects,
and finally without any exclusion.
Methods
Subjects
The study sample was composed of 230 monozygotic (MZ) twins
(85 men), 305 dizygotic (DZ) twins (111 men), and 257 singleton
siblings (98 men) from 339 families, all registered in the Netherlands
Twin Register (NTR). Their average age was 31.3 (SD 11.2) years.
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Zygosity of the twins was determined by DNA typing. The Ethics
Committee of the Vrije Universiteit approved of the study protocol,
and all subjects gave written consent before entering the study. No
payment was made for participation, but all subjects received an
annotated review of their BP recording.
Procedures
Subjects were visited in the morning before going to work and were
requested to refrain from intense physical activity on the preceding
and the ambulatory monitoring days. A Spacelabs 90207 ABP
monitor (Redmont, Wash) and an ambulatory ECG/ICG recorder,17
which includes a vertical accelerometer, were attached to the subject
and the operation was explained. Arm circumference was measured
to choose the appropriate arm-cuff size. BP measurements were
initiated automatically every 30 minutes. Before inflating, the device
gave an auditory 2-tone beep to warn participants to keep their arm
as still and relaxed as possible. Subjects were unable to observe their
own BP readings. The monitor was programmed to retake a
measurement 2 minutes after a misreading. Every 30 (10) minutes,
subjects were prompted by an auditory beep to write down a
chronological account of activity (eg, deskwork, housekeeping,
watching TV), posture (lying, sitting, standing, walking, and bicy-
cling), and location (eg, at home, at work, at a public place). When
they went to bed, participants removed the BP monitor. The signal
from the vertical accelerometer was combined with the diary
information to check the diary entries on posture and physical
activity for accuracy.
Data Reduction
Previous recommendations for excluding artifacts and outliers from
ambulatory recordings were followed.18 The reported times of diner
and lunch, awakening, and bedtime were used to compute mean SBP
and DBP across all readings in the morning, afternoon, and evening.
To assess the confounding of different physical activity patterns on
ABP levels, we also computed the average ABP on the 3 periods of
the day using only BP values obtained during sitting activities.
Applying European Society of Hypertension criteria, hypertension
was considered present when subjects were currently using pre-
scribed antihypertensive medication or when mean daytime ABP
was higher than 135/85 mm Hg.19
Statistical Analysis
Heritability estimates of hypertension and daytime ABP were ob-
tained from structural equation modeling of the MZ and DZ/sib
variances and covariances using the structural equation program
Mx.20 Hypertension heritability was assessed using a liability–
threshold model, which assumes a latent, normally distributed
liability to disease that is manifest as a categorical phenotype.21 For
ABP, the best-fitting trivariate model was used to estimate the
relative contribution of genetic and environmental influences to the
variance of the 3 daytime period means of SBP and DBP. A detailed
description of the model-fitting procedures is found in the online
supplement available at http://www.hypertensionaha.org.
These analyses on ABP were performed 3 times, in 3 different sets
of subjects. In the normotensive set, we excluded all subjects with
hypertension diagnosed (ABP 135/85) and subjects using antihy-
pertensive medication. In the second and unmedicated set, we only
excluded the 29 subjects using antihypertensive medication. The
third set included all available subjects. To obtain ABP values in
these medicated subjects, drug class-specific treatment effect aver-
ages, obtained from a recent large systematic review of the effect of
antihypertensive treatment on ambulatory BP,6 were added to the
observed pressures. Unlike substitution methods, this adjustment
makes no assumptions regarding the underlying reasons for treat-
ment and keeps the relative ranking of the treated subjects intact.
Results
On average, 27 (4) BP measurements (13.5 hours) took
place during the recording period, of which, on average, 13
(5) were during sitting posture (6.5 hours, which is 48%
of the total monitoring period). Although the sample was
previously selected based on the presence of at least 2 family
members with extreme scores on personality questionnaires,
their scores did not correlate significantly with hypertension
diagnosis, or with SBP and DBP. Throughout the day, men
had significantly higher SBP and DBP than women. At all 3
periods, age was significantly correlated with SBP (0.24 to
0.33) and DBP (0.31 to 0.35). Both sex and age were kept as
covariates in all further model-fitting analyses.
Body mass index correlated significantly with both SBP
(0.24 to 0.31) and DBP (0.20 to 0.25). Because several
studies reported a genetic covariation between BP and body
mass index,4,22,23 and because genetic variance is removed
when shared genes influence both variable and covariate, we
intentionally did not include body mass index as covariate.
Hypertension
In our sample, 115 (14.5%) of the 792 subjects received a
hypertension diagnosis based on their ambulatory recording,
with 29 of them receiving antihypertensive medication.
Among the hypertensive were 31 MZ twins. The homogene-
ity of covariances over the sexes and between DZ twins and
siblings was confirmed, and no evidence for a difference in
twin pair versus singleton sibling pair correlation in hyper-
tensive risk was found. The liability threshold was higher for
women compared with men, and higher for younger versus
older subjects. The sex- and age-corrected tetrachorical cor-
relations for the liability dimension were 0.62 for MZ twins
and 0.29 for DZ twins, indicating genetic influences. This
was confirmed by model fitting, the results of which are
shown in Table 1. Leaving out both shared environmental and
genetic influences from the model (E-model) caused a large
increase in 2, indicating a significant worsening of the fit.
This shows a clear influence of familial factors on hyperten-
sion. Statistical power was insufficient to discriminate be-
TABLE 1. Model Fitting Results for Hypertension
Model 2 df P AIC A, % C, % E, %
ACE — — — — 61 (0–83) 0 (0–49) 39 (17–75)
AE 0 1 1.000 2.000 61 (33–83) — 39 (17–67)
CE 2.355 1 0.125 0.356 — 37 (18–56) 63 (44–82)
E 18.914 2 0.000 14.914 — — 100
Shown are 2 values and gain in degrees of freedom of the models and accompanying estimates for additive
genetic (A) and shared (C) and unique environmental (E) influences.
AIC indicates Akaike information criterion.
The 95% confidence intervals are given in parentheses.
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tween genetic influences and shared environmental influ-
ences, but given the pattern of twin correlations and the
values of Akaike’s Information Criterion of the AE and CE
models, it is most likely that the AE model is the preferred
model. In the AE model, variance in hypertension diagnosis
is, for 61%, explained by genetic influences.
Ambulatory BP
Table 2 presents the mean ABP for the 3 periods of the day
in the normotensive, unmedicated, and full set of subjects. It
illustrates the impact of excluding subjects with hypertension
and/or using antihypertensive medication. Although the
means do not dramatically change (2% to 4.5%), strict
exclusion brings about a 30% to 39% reduction in the
standard deviation in comparison to the “true” population.
Exclusion of medicated subjects led to much smaller changes
in means (0.5% to 0.5%) and moderate reductions in
standard deviations (1% to 10.5%). Next, the resemblance
between MZ twins and between DZ twins or sibling pairs was
examined by calculating age-adjusted Pearson correlations,
stratified by sex, as shown in Table 3. Throughout, a larger
MZ than DZ correlation is evident, suggesting the presence of
additive genetic and unique environmental influences.
Multivariate Genetic Analyses
The means and variances of both SBP and DBP were equal
for MZ and DZ twins and for singleton siblings. Importantly,
we found no twin–singleton differences in ABP in all 3 sets
of subjects, suggesting that results obtained in twins can be
generalized to singletons.
Multivariate model-fitting resulted in the preference for a
model without shared environmental factors (AE model) over
the full model (ACE model) for all 3 sets of subjects.
Statistical power was sufficient to discern the AE and CE
model, because quantitative analyses have higher statistical
power than the ordinal analyses performed for hypertension
status. Although there was sufficient power (at 0.80,
0.05) to detect effects of 23% or higher, no significant
common environmental effect was found. We further tested
the hypothesis that a common latent trait was underlying BP
TABLE 2. Means (SD) for Ambulatory SBP and DBP at the 3 Daily Periods
Time of Day BP (mm Hg) Sex
Normotensives
(645N657)
Unmedicated Set of Subjects
(747N759)
Full Set of Subjects
(772N786)
Morning SBP M 129.8 (9.1) 133.5 (11.4) 134.2 (12.1)
F 124.2 (8.3) 125.9 (10.1) 126.7 (11.3)
DBP M 79.3 (6.4) 82.5 (8.7) 83.2 (9.4)
F 77.4 (6.5) 80.8 (7.5) 81.3 (8.3)
Afternoon SBP M 129.6 (8.1) 132.6 (10.1) 133.2 (10.9)
F 122.9 (8.5) 125.9 (10.1) 125.3 (10.2)
DBP M 77.4 (6.4) 80.4 (8.2) 81.1 (8.9)
F 77.4 (6.0) 78.6 (7.1) 79.1 (7.7)
Evening SBP M 129.0 (8.5) 132.1 (10.4) 132.7 (10.9)
F 122.9 (8.1) 124.7 (10.1) 125.3 (10.8)
DBP M 76.0 (6.3) 79.3 (8.7) 79.9 (9.2)
F 76.6 (6.8) 77.9 (7.8) 78.4 (8.4)
SD indicates standard deviation; BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure;
M, male; F, female.
TABLE 3. Resemblance Between MZ and DZ/Sib Pairs for Ambulatory SBP and DBP
Time of Day Sex of Pairs
SBP DBP
rMZ rDZ/sib rMZ rDZ/sib
Morning M 0.72/0.60/0.68 0.38/0.38/0.41 0.42/0.63/0.68 0.21/0.34/0.40
F 0.44/0.56/0.49 0.13/0.23/0.27 0.34/0.51/0.51 0.21/0.28/0.33
Opposite sex — 0.09/0.16/0.26 — 0.16/0.12/0.10
Afternoon M 0.40/0.62/0.60 0.27/0.25/0.32 0.63/0.70/0.65 0.38/0.39/0.43
F 0.59/0.68/0.64 0.18/0.23/0.27 0.62/0.72/0.73 0.30/0.30/0.35
Opposite sex — 0.08/0.18/0.26 — 0.19/0.14/0.15
Evening M 0.34/0.49/0.59 0.35/0.32/0.39 0.31/0.49/0.56 0.17/0.45/0.43
F 0.19/0.35/0.40 0.18/0.19/0.27 0.21/0.43/0.45 0.18/0.21/0.27
Opposite sex — 0.17/0.11/0.24 — 0.18/0.09/0.15
Shown are the age-corrected correlations for the normotensive set of subjects/the set excluding medicated
subjects/the full set of subjects (with ABP corrected for medication).
Correlations that are significant at a 0.05 level are in bold.
MZ indicates monozygotic; DZ, dizygotic; sib, singleton siblings.
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at all 3 periods of the day (common pathway model). This
model was preferred over the initial independent pathway
model in all 3 sets of subjects. We found no specific genetic
influences for each of the daily periods, and the largest part of
unique environmental influences was also common to all 3
periods. Table 4 shows the common pathway estimates for A,
which corresponds to the heritability, and for E, which
corresponds to the influence of the common environmental
factor. The specific E estimates represent unique environmental
influences that are specific to each of the periods of the day.
The highest heritability estimates were found in the full set
of subjects. In comparison to the results on the normotensive
subjects, heritability estimates were substantially higher
(SBP, 7% to 12%; DBP, 8% to 15%). Furthermore,
confidence intervals were wider for the normotensive sub-
jects compared with the full set of subjects. An increase in
heritability was already seen when unmedicated subjects
were included, but only when medicated subjects were
included did we find nonoverlapping confidence intervals
with the normotensives.
Individual differences in daily physical activity on the
measurement day did not confound the genetic analyses of
ABP. When these analyses were repeated using BP measure-
ments obtained during sitting activities, the results were
essentially unchanged.
Discussion
Based on daytime ambulatory measurements of SBP and
DBP, obtained in 792 twins and singleton siblings, the
present study showed that the individual differences in
hypertension status are, for 61%, genetically determined.
Heritability estimates for ambulatory SBP and DBP were
between 44% and 63% when no exclusion criteria were
upheld. These estimates correspond well to those found in
previous ambulatory and laboratory/clinical studies in other
large adolescent and adult healthy twin samples.2,10,12,13 Our
study had a number of strengths in design that provide
confidence in its outcome. The extended twin design in-
creases the statistical power to distinguish between compo-
nents of A, C, and E compared with a design including only
MZ and DZ twins.15 Furthermore, it allowed us to test the
possibility that results obtained on singleton sibling pairs
differed somehow from those obtained in twin pairs. This is
important because the lower birth weight in twins might be
considered to reflect an impaired fetal environment, which,
according to the “Barker hypothesis,” may impact on BP
regulation.24 By comparing singletons with twins from the
same family, the 2 comparison groups are perfectly matched
for familial influences (same parents, same womb, although
at a different time, and same family environment). Our
analyses showed that MZ and DZ twins and singleton siblings
did not differ from each other in means or variances on any
of the ABP measures. Importantly, sibling–sibling covariance
did not differ from sibling–twin or DZ–twin covariance,
which strongly argues against a special twin intrauterine
disadvantage with deleterious effects on adult ABP. The
absence of any twin–singleton difference repeats previous
findings in resting laboratory BP25 and indicates that esti-
mates of the heritability of ABP from twin studies are not
systematically biased and can be generalized to the general
population.
Exclusion of hypertensive subjects clearly distorted MZ
and DZ twin correlations, as well as the variances. Excluding
medicated subjects further increased the distortion, although
the effect was only very minor in this population. Our results
showed that restricting the sample to normotensives only not
only caused a decrease in total variance but also specifically
reduced heritability estimates. With this result, we extend the
earlier findings of Cui et al26 on conventional office BP to
prolonged BP measurements in naturalistic settings. The
effect of excluding groups of subjects, on grounds of hyper-
tension and/or medication, is undesirable because the reduced
heritability estimates directly lead to a loss of power in
linkage studies. This effect was convincingly illustrated by
Hunt et al,27 who showed that removing medicated subjects
from the sample led to the disappearance of a quantitative
trait locus for conventional office SBP on chromosome 6.
The substantial heritability of office BP has motivated
many large-scale efforts to identify hypertension-
predisposing genes through linkage28 approaches. Because
ABP is a better predictor of target organ damage,7 cardiovas-
cular morbidity, and mortality8,9 than office BP, these gene
finding attempts may be well-served by using ABP. Here, we
show that genetic variance of ABP is sufficiently high to
justify its use in genome searches. The repeated-measures
TABLE 4. Heritability Estimates for SBP and DBP Under the
Common Pathway Model
BP Time of Day
Common Pathway, % Specific, %
A E E
Normotensive set of subjects
DBP Morning 40 (28–53) 23 (13–35) 37 (31–44)
Afternoon 55 (39–70) 30 (19–47) 15 (9–21)
Evening 31 (20–41) 17 (10–28) 52 (46–59)
SBP Morning 38 (24–51) 29 (18–44) 32 (27–38)
Afternoon 50 (32–65) 38 (24–56) 12 (7–18)
Evening 32 (19–44) 24 (14–38) 44 (38–50)
Unmedicated set of subjects
DBP Morning 52 (39–63) 23 (15–36) 24 (20–29)
Afternoon 61 (46–73) 27 (17–41) 12 (7–14)
Evening 43 (32–53) 19 (12–30) 37 (32–42)
SBP Morning 49 (34–62) 30 (18–45) 22 (18–26)
Afternoon 57 (41–71) 35 (22–51) 9 (6–12)
Evening 42 (29–54) 26 (16–39) 38 (27–36)
Full set of subjects
DBP Morning 55 (43–65) 23 (15–35) 22 (18–26)
Afternoon 63 (50–74) 27 (17–39) 10 (7–14)
Evening 46 (35–56) 19 (12–29) 35 (30–39)
SBP Morning 50 (38–61) 30 (20–42) 20 (17–24)
Afternoon 57 (44–69) 34 (24–48) 9 (6–12)
Evening 44 (33–55) 27 (18–38) 29 (25–34)
Shown are the heritability estimates for the normotensive set of subjects, the
unmedicated set of subjects, and the full set of subjects.
The 95% confidence intervals are given in parentheses.
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structure inherent in ambulatory monitoring brings further
advantages. We separated the entire ambulatory recording
into 3 daily periods, allowing for the possibility that different
genetic factors would affect BP regulation during leisure
(evening) and work (morning, afternoon) periods. For both
SBP and DBP, a common factor influenced all 3 periods.
There were no separate genetic factors influencing BP at
different periods of the day. From a gene finding point of
view, the common genetic factor structure is advantageous on
2 accounts. The repeated-measures structure increases statis-
tical power to find genes in linkage analysis.29 Additionally,
these genes, by virtue of having a pervasive influence on SBP
or DBP across all situations, will also have the largest clinical
relevance.
Limitations
An important limitation to our study is the lack of night-time
recordings. We opted not to burden our subjects by asking
them to continue wearing the BP monitor at night. In our
experience, this causes large attrition in nonpatient popula-
tions. In family-based studies, the loss of a single subject is
more hard-felt than in population samples, in which an
additional randomly drawn subject can be easily recruited
without loss to the overall study design. It is possible,
however, that different genetic factors come into play during
the day than at night. Some indication for this possibility,
although the confidence intervals of the estimates for the 3
daily periods were overlapping, is seen in the systematically
lower heritability in the evening compared with morning and,
particularly, afternoon recordings.
Our sample consisted of young white adults aged mainly
between 20 and 40, with an age range between 15 and 81
years. Therefore, generalization of our results beyond the
main age range or to a population of different ethnicity should
be performed only hesitantly. A recent family study per-
formed an age-stratified longitudinal genetic analysis of
office BP and found little variation in the genetic architecture
over time.30 This suggests that a common set of genes may be
contributing to the observed variation in BP across a wide age
range. In our sample, separating the analyses of ABP over
multiple age cohorts would have compromised statistical
power to detect, for instance, twin–singleton differences.
Perspectives
Genetic contribution to the variance in BP is very likely to be
polygenic, with only very small contributions of the individ-
ual QTLs to the final hypertensive risk. Future gene-finding
studies, particularly linkage studies, should therefore aim to
maximize statistical power. In this regard, ABP monitoring
has a number of advantages over conventional office mea-
surements. Heritability of ABP is comparable to office BP,
but the genes underlying ABP are likely to have better
predictive validity for target organ damage,7 cardiovascular
morbidity, and mortality.8,9 Ambulatory recording has an
intrinsic multivariate nature, and the repeated, highly corre-
lated BP measures can be exploited to reduce measurement
error and improve the estimation of the latent genetic factor.
Our findings further show that a part of the genetic variance
in ABP is lost when hypertensive (and/or medicated) subjects
are excluded. In future linkage and association studies, such
exclusion should be avoided.
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